General Information of Drug (ID: DMC3IGK)

Drug Name
1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide
Synonyms CHEMBL1173603
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 229.25
Logarithm of the Partition Coefficient (xlogp) 2.1
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C13H13N2O2+
IUPAC Name
(1-methylpyridin-1-ium-3-yl) N-phenylcarbamate
Canonical SMILES
C[N+]1=CC=CC(=C1)OC(=O)NC2=CC=CC=C2
InChI
InChI=1S/C13H12N2O2/c1-15-9-5-8-12(10-15)17-13(16)14-11-6-3-2-4-7-11/h2-10H,1H3/p+1
InChIKey
HFCGFRPAGMNQAZ-UHFFFAOYSA-O
Cross-matching ID
PubChem CID
49799304
TTD ID
D0OJ9P
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cholinesterase (BCHE) TTEB0GD CHLE_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93.